This report contains market size and forecasts of NK Cell Therapy in Global, including the following market information:
Global NK Cell Therapy Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global NK Cell Therapy market was valued at 308 million in 2020 and is projected to reach US$ 548.1 million by 2027, at a CAGR of 15.5% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the NK Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
ALSO READ : http://www.marketwatch.com/story/nk-cell-therapy-market-research-re...
Total Market by Segment:
Global NK Cell Therapy Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global NK Cell Therapy Market Segment Percentages, By Type, 2020 (%)
NK Cell Therapies
NK Cell Directed Antibodies
China NK Cell Therapy Market, By Application, 2016-2021, 2022-2027 ($ millions)
China NK Cell Therapy Market Segment Percentages, By Application, 2020 (%)
Cancer
Gastrointestinal Diseases
Others
Global NK Cell Therapy Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global NK Cell Therapy Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
ALSO READ : http://www.marketwatch.com/story/cable-foil-market-research-report-...
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total NK Cell Therapy Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
ALSO READ : http://www.marketwatch.com/story/collision-avoidance-sensors-market...
Total NK Cell Therapy Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
ALSO READ : http://www.marketwatch.com/story/high-density-polyethylene-market-r...
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 NK Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global NK Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global NK Cell Therapy Overall Market Size
2.1 Global NK Cell Therapy Market Size: 2021 VS 2027
2.2 Global NK Cell Therapy Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top NK Cell Therapy Players in Global Market
3.2 Top Global NK Cell Therapy Companies Ranked by Revenue
3.3 Global NK Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 NK Cell Therapy Companies in Global Market, by Revenue in 2020
3.5 Global Companies NK Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 NK Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 NK Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 NK Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global NK Cell Therapy Market Size Markets, 2021 & 2027
4.1.2 NK Cell Therapies
4.1.3 NK Cell Directed Antibodies
4.2 By Type - Global NK Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global NK Cell Therapy Revenue, 2016-2021
4.2.2 By Type - Global NK Cell Therapy Revenue, 2022-2027
4.2.3 By Type - Global NK Cell Therapy Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
ALSO READ : http://www.marketwatch.com/story/regional-caustic-soda-prills-99-in...
5.1.1 By Application - Global NK Cell Therapy Market Size, 2021 & 2027
5.1.2 Cancer
5.1.3 Gastrointestinal Diseases
5.1.4 Others
5.2 By Application - Global NK Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global NK Cell Therapy Revenue, 2016-2021
5.2.2 By Application - Global NK Cell Therapy Revenue, 2022-2027
5.2.3 By Application - Global NK Cell Therapy Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global NK Cell Therapy Market Size, 2021 & 2027
6.2 By Region - Global NK Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global NK Cell Therapy Revenue, 2016-2021
6.2.2 By Region - Global NK Cell Therapy Revenue, 2022-2027
6.2.3 By Region - Global NK Cell Therapy Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America NK Cell Therapy Revenue, 2016-2027
6.3.2 US NK Cell Therapy Market Size, 2016-2027
6.3.3 Canada NK Cell Therapy Market Size, 2016-2027
6.3.4 Mexico NK Cell Therapy Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe NK Cell Therapy Revenue, 2016-2027
6.4.2 Germany NK Cell Therapy Market Size, 2016-2027
6.4.3 France NK Cell Therapy Market Size, 2016-2027
6.4.4 U.K. NK Cell Therapy Market Size, 2016-2027
6.4.5 Italy NK Cell Therapy Market Size, 2016-2027
6.4.6 Russia NK Cell Therapy Market Size, 2016-2027
6.4.7 Nordic Countries NK Cell Therapy Market Size, 2016-2027
6.4.8 Benelux NK Cell Therapy Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia NK Cell Therapy Revenue, 2016-2027
6.5.2 China NK Cell Therapy Market Size, 2016-2027
6.5.3 Japan NK Cell Therapy Market Size, 2016-2027
6.5.4 South Korea NK Cell Therapy Market Size, 2016-2027
6.5.5 Southeast Asia NK Cell Therapy Market Size, 2016-2027
6.5.6 India NK Cell Therapy Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America NK Cell Therapy Revenue, 2016-2027
6.6.2 Brazil NK Cell Therapy Market Size, 2016-2027
6.6.3 Argentina NK Cell Therapy Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa NK Cell Therapy Revenue, 2016-2027
6.7.2 Turkey NK Cell Therapy Market Size, 2016-2027
6.7.3 Israel NK Cell Therapy Market Size, 2016-2027
6.7.4 Saudi Arabia NK Cell Therapy Market Size, 2016-2027
6.7.5 UAE NK Cell Therapy Market Size, 2016-2027
7 Players Profiles
7.1 Nektar Therapeutics
7.1.1 Nektar Therapeutics Corporate Summary
7.1.2 Nektar Therapeutics Business Overview
7.1.3 Nektar Therapeutics NK Cell Therapy Major Product Offerings
7.1.4 Nektar Therapeutics NK Cell Therapy Revenue in Global (2016-2021)
7.1.5 Nektar Therapeutics Key News
7.2 Innate Pharma SA
7.2.1 Innate Pharma SA Corporate Summary
7.2.2 Innate Pharma SA Business Overview
7.2.3 Innate Pharma SA NK Cell Therapy Major Product Offerings
7.2.4 Innate Pharma SA NK Cell Therapy Revenue in Global (2016-2021)
7.2.5 Innate Pharma SA Key News
7.3 Affimed
7.3.1 Affimed Corporate Summary
7.3.2 Affimed Business Overview
7.3.3 Affimed NK Cell Therapy Major Product Offerings
7.3.4 Affimed NK Cell Therapy Revenue in Global (2016-2021)
7.3.5 Affimed Key News
7.4 Chipscreen Biosciences
7.4.1 Chipscreen Biosciences Corporate Summary
7.4.2 Chipscreen Biosciences Business Overview
7.4.3 Chipscreen Biosciences NK Cell Therapy Major Product Offerings
7.4.4 Chipscreen Biosciences NK Cell Therapy Revenue in Global (2016-2021)
7.4.5 Chipscreen Biosciences Key News
7.5 Fate Therapeutics
7.5.1 Fate Therapeutics Corporate Summary
7.5.2 Fate Therapeutics Business Overview
7.5.3 Fate Therapeutics NK Cell Therapy Major Product Offerings
7.5.4 Fate Therapeutics NK Cell Therapy Revenue in Global (2016-2021)
7.5.5 Fate Therapeutics Key News
7.6 Glycostem Therapeutics
7.6.1 Glycostem Therapeutics Corporate Summary
7.6.2 Glycostem Therapeutics Business Overview
7.6.3 Glycostem Therapeutics NK Cell Therapy Major Product Offerings
7.6.4 Glycostem Therapeutics NK Cell Therapy Revenue in Global (2016-2021)
7.6.5 Glycostem Therapeutics Key News
7.7 Dragonfly Therapeutics
7.7.1 Dragonfly Therapeutics Corporate Summary
7.7.2 Dragonfly Therapeutics Business Overview
7.7.3 Dragonfly Therapeutics NK Cell Therapy Major Product Offerings
7.4.4 Dragonfly Therapeutics NK Cell Therapy Revenue in Global (2016-2021)
7.7.5 Dragonfly Therapeutics Key News
7.8 Kiadis Pharma
7.8.1 Kiadis Pharma Corporate Summary
7.8.2 Kiadis Pharma Business Overview
7.8.3 Kiadis Pharma NK Cell Therapy Major Product Offerings
7.8.4 Kiadis Pharma NK Cell Therapy Revenue in Global (2016-2021)
7.8.5 Kiadis Pharma Key News
7.9 NantWorks
7.9.1 NantWorks Corporate Summary
7.9.2 NantWorks Business Overview
7.9.3 NantWorks NK Cell Therapy Major Product Offerings
7.9.4 NantWorks NK Cell Therapy Revenue in Global (2016-2021)
7.9.5 NantWorks Key News
7.10 Nkarta Therapeutics
7.10.1 Nkarta Therapeutics Corporate Summary
7.10.2 Nkarta Therapeutics Business Overview
7.10.3 Nkarta Therapeutics NK Cell Therapy Major Product Offerings
7.10.4 Nkarta Therapeutics NK Cell Therapy Revenue in Global (2016-2021)
7.10.5 Nkarta Therapeutics Key News
7.11 Fortress Biotech
7.11.1 Fortress Biotech Corporate Summary
7.11.2 Fortress Biotech Business Overview
7.11.3 Fortress Biotech NK Cell Therapy Major Product Offerings
7.11.4 Fortress Biotech NK Cell Therapy Revenue in Global (2016-2021)
7.11.5 Fortress Biotech Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
....continued

CONTACT DETAILS
[email protected]
+44 203 500 2763
+1 62 825 80070
971 0503084105